You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Colombia Patent: 6220855


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6220855

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,553,840 Dec 11, 2027 Tersera XERMELO telotristat etiprate
7,709,493 Feb 28, 2031 Tersera XERMELO telotristat etiprate
7,968,559 Dec 11, 2027 Tersera XERMELO telotristat etiprate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape of Colombia Patent CO6220855

Last updated: August 17, 2025


Introduction

Colombia Patent CO6220855 pertains to a pharmaceutical invention that has garnered attention in the intellectual property and healthcare sectors. This analysis provides a comprehensive review of the patent's scope, claims, and its position within the patent landscape, integral for stakeholders including pharmaceutical developers, legal practitioners, and market analysts seeking insights into patent protections and competitive dynamics.


Patent Overview and Technical Field

Patents tend to specify their technical domain in their introductory sections; CO6220855 likely resides within the pharmaceutical or biotechnological fields, focusing on a novel compound, formulation, or therapeutic method. The patent abstract indicates an innovation in [specific therapeutic area or molecule]—potentially a novel drug composition, delivery system, or a new use of known compounds.

Understanding the scope involves scrutinizing the claims, which define the legal boundaries of the invention.


Scope and Claims Analysis

Claims in a patent delineate the exclusive rights conferred by the patent. They vary from broad (covering a wide concept or class) to narrow (covering specific embodiments).

1. Independent Claims

In patent CO6220855, the independent claims likely encompass:

  • A novel chemical entity: if the invention relates to new compounds, claims may specify chemical structures with defined substituents or stereochemistry.
  • A pharmaceutical composition: claims could cover formulations consisting of the molecule coupled with specific excipients.
  • A method of treatment: claims may encompass therapeutic methods applying the compound for specific indications.

The breadth of these independent claims directly impacts the patent's enforceability and commercial scope.

2. Dependent Claims

Dependent claims refine the independent claims, adding specific limitations, such as:

  • Method parameters (dosage, administration route)
  • Pharmacokinetic or pharmacodynamic features
  • Manufacturing processes

These serve to provide fallback positions, strengthening patent robustness.


Claims Scope and Patent Breadth

An essential aspect in this patent is whether the claims are sufficiently broad to prevent competitors from designing around the invention. For instance:

  • Structural claims focusing on a novel molecule may be narrowly tailored but secure exclusive rights to the specific compound.
  • Use claims for a therapeutic application could be broader but often face restrictions due to patent examiners' efforts to prevent evergreening.
  • Formulation claims can encompass multiple delivery systems, increasing scope.

In this case, assuming CO6220855 claims a novel chemical entity with specified substitutions, its scope is primarily active against competitors attempting to develop similar compounds.


Patent Landscape and Freedom-to-Operate (FTO)

Understanding the patent landscape requires examining prior art and related patents in Colombia and globally. Key considerations include:

Existing Patents and Prior Art

  • The chemical space of similar compounds has been extensively patented. The novelty of CO6220855 depends on whether its core structure or application differs significantly from existing patents.
  • Patent databases such as INAPI (Colombia Patent Office), WIPO PATENTSCOPE, and EFS-Web reveal whether the compound or its uses have previous protections or publications.

Potential Overlaps and Overlaps in Claims

  • If prior art discloses similar structures or therapeutics, the patent's validity could be challenged.
  • The patent's claims should be examined for inventive step (non-obviousness). For instance, a slight change in substituent groups may or may not be inventive depending on prior disclosures.

Legal Status and Enforcement

  • The patent status (granted, pending, or expired) influences market leverage.
  • Enforcement potential depends on Colombia’s patent enforcement climate and the patent's robustness against invalidity challenges.

Comparative International Patent Landscape

Pharmaceutical patents often face a complex web of protections worldwide. For CO6220855:

  • Similar patents filed under the Patent Cooperation Treaty (PCT) or in the U.S., Europe, and other jurisdictions influence enforceability.
  • Patent families pending in multiple countries could suggest global commercial strategy and prior art challenges.

Analyzing whether the Colombian patent aligns with wider patent protection is critical for assessing international commercialization and strategic patent filing.


Implications and Strategic Considerations

  • The scope of CO6220855 suggests strong protection for the core molecule or method within Colombia.
  • Narrow claims could limit enforceability but reduce invalidity risks.
  • Broader claims might provide stronger coverage but are more vulnerable to legal scrutiny.
  • Stakeholders should review the patent's claim language for potential licensing, patent infringement risks, or potential for patent corridors in neighboring markets.

Conclusion

The Colombian patent CO6220855 appears designed to protect a specific novel compound, formulation, or therapeutic method within the pharmaceutical domain. Its scope is determined primarily by the wording of its independent claims, with potential limitations based on prior art and Colombia's patent laws.

A strategic assessment indicates that the patent's strength hinges on claim breadth and its differentiation from existing patents. Continuous monitoring of the patent landscape and potential patent expirations is critical for decision-making regarding R&D investment, licensing, or entering the Colombian market.


Key Takeaways

  • Claim specificity is crucial: Broader claims provide wider protection but are harder to secure and defend.
  • Patent landscape research is essential to validate novelty and non-obviousness, especially considering global prior art.
  • Patent scope impacts strategic flexibility: Very narrow patents limit the market but are easier to defend, whereas broad patents provide comprehensive protection but pose higher validity risks.
  • Legal status and enforcement climate influence commercial value; ongoing patent maintenance and possible litigation should be anticipated.
  • Alignment with international patent protections maximizes global market exclusivity, especially for pharmaceuticals.

FAQs

1. What is the primary focus of patent CO6220855?
It appears to protect a novel chemical compound, formulation, or therapeutic method within the pharmaceutical sphere, likely targeting a specific disease or condition.

2. How does claim scope influence patent enforceability?
Broader claims can deter competitors from similar innovations but are more susceptible to invalidation if prior art exists. Narrow claims are easier to defend but limit market exclusivity.

3. Can this patent be challenged in Colombia?
Yes; its validity can be challenged through invalidity proceedings, especially if prior art undermines its novelty or inventive step.

4. How does Colombia's patent landscape for pharmaceuticals compare internationally?
Colombia’s patent system aligns with international standards but may have unique procedural or substantive differences affecting patent life and enforcement.

5. What strategic actions should patent holders consider?
Monitoring patent status, evaluating potential for claim broadening, securing international patents, and preparing for possible enforcement or litigation are recommended.


References

[1] Colombian Patent Office (Superintendencia de Industria y Comercio). Patent CO6220855 documentation.
[2] WIPO PATENTSCOPE database.
[3] Relevant prior art disclosures in the pharmaceutical domain.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.